CNFG
LLY icon

Creegan & Nassoura Financial Group’s Eli Lilly LLY Stock Holding History

Creegan & Nassoura Financial Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-232
Closed -$206K – 77
2024
Q3 		$206K Buy
+232
New +$209K 0.13% 77

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Creegan & Nassoura Financial Group's LLY Position: Q4 2024 in Review

Creegan & Nassoura Financial Group sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 232 shares — an estimated $206K sold.

Creegan & Nassoura Financial Group first reported a position in LLY in Q3 2024 and held it in 1 quarter. The position peaked at $206K in Q3 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Creegan & Nassoura Financial Group reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
  • Creegan & Nassoura Financial Group sold 232 Eli Lilly shares in Q4 2024, an estimated $206K.
  • Creegan & Nassoura Financial Group first reported a position in Eli Lilly in Q3 2024 and held it in 1 quarter.
  • Creegan & Nassoura Financial Group's Eli Lilly position peaked at $206K in Q3 2024.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Creegan & Nassoura Financial Group's 13F filing for Q4 2024, filed 14 Feb 2025.